Literature DB >> 27551833

Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes.

Jinyun Dong1, Qijing Zhang1, Qing Cui1, Guang Huang1, Xiaoyan Pan2, Shaoshun Li3.   

Abstract

The human cytochrome P450 family 1 enzymes consist of three members, CYP1A1, CYP1A2 and CYP1B1, which are predominantly involved in the phase I metabolism of xenobiotics. Because they have been implicated in carcinogenesis, cancer progression, and drug resistance, the inhibition of these enzymes has been widely considered an effective oncological therapeutic strategy. Some natural and synthetic flavonoids and naphthoflavonoids have been extensively documented to exert pronounced influence in the modulation of CYP1s, including functioning as inhibitors, substrates, and aryl hydrocarbon receptor (AhR) ligands. However, the molecular determinants behind these effects are still unknown. This review summarizes the structural features responsible for the CYP1 inhibitory effects of the reported flavonoids and naphthoflavonoids. Additionally, a three-dimensional quantitative structure-activity relationship (3D-QSAR) study was performed to better understand the effect of their structural properties on biological activities. We hope this review provides a useful foundation for the rational design of potent and selective CYP1 isozyme inhibitors, thereby accelerating the drug discovery process.
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CYP1 inhibitors; drug discovery; flavonoids; naphthoflavonoids; oxidoreductases

Mesh:

Substances:

Year:  2016        PMID: 27551833     DOI: 10.1002/cmdc.201600316

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  12 in total

1.  Development of benzochalcone derivatives as selective CYP1B1 inhibitors and anticancer agents.

Authors:  Jinyun Dong; Guang Huang; Qijing Zhang; Zengtao Wang; Jiahua Cui; Yan Wu; Qingqing Meng; Shaoshun Li
Journal:  Medchemcomm       Date:  2019-07-02       Impact factor: 3.597

2.  Molecular docking analyses of CYP450 monooxygenases of Tribolium castaneum (Herbst) reveal synergism of quercetin with paraoxon and tetraethyl pyrophosphate: in vivo and in silico studies.

Authors:  Ammarah Ghaffar; Sheikh Arslan Sehgal; Rida Fatima; Roya Batool; Ume Aimen; Sliha Awan; Sajida Batool; Faheem Ahmad; Syed M Nurulain
Journal:  Toxicol Res (Camb)       Date:  2020-05-09       Impact factor: 3.524

3.  Structure-Based Design and Synthesis of New Estrane-Pyridine Derivatives as Cytochrome P450 (CYP) 1B1 Inhibitors.

Authors:  Raphaël Dutour; Francisco Cortés-Benítez; Jenny Roy; Donald Poirier
Journal:  ACS Med Chem Lett       Date:  2017-10-11       Impact factor: 4.345

4.  Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy via screening of a natural product repository.

Authors:  Prashant Joshi; Vinay R Sonawane; Ibidapo S Williams; Glen J P McCann; Linda Gatchie; Rajni Sharma; Naresh Satti; Bhabatosh Chaudhuri; Sandip B Bharate
Journal:  Medchemcomm       Date:  2018-01-08       Impact factor: 3.597

5.  Newborn Mice Lacking the Gene for Cyp1a1 Are More Susceptible to Oxygen-Mediated Lung Injury, and Are Rescued by Postnatal β-Naphthoflavone Administration: Implications for Bronchopulmonary Dysplasia in Premature Infants.

Authors:  Paramahamsa Maturu; Yanhong Wei-Liang; Weiwu Jiang; Lihua Wang; Krithika Lingappan; Roberto Barrios; Yao Liang; Bhagavatula Moorthy; Xanthi I Couroucli
Journal:  Toxicol Sci       Date:  2017-05-01       Impact factor: 4.849

Review 6.  Cancer chemoprevention through dietary flavonoids: what's limiting?

Authors:  Haneen Amawi; Charles R Ashby; Amit K Tiwari
Journal:  Chin J Cancer       Date:  2017-06-19

7.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

Review 8.  Plant Occurring Flavonoids as Modulators of the Aryl Hydrocarbon Receptor.

Authors:  Elizabeth Goya-Jorge; María Elisa Jorge Rodríguez; Maité Sylla-Iyarreta Veitía; Rosa M Giner
Journal:  Molecules       Date:  2021-04-16       Impact factor: 4.411

9.  Development of 2-arylbenzo[h]quinolone analogs as selective CYP1B1 inhibitors.

Authors:  Jinyun Dong; Zengtao Wang; Qingqing Meng; Qijing Zhang; Guang Huang; Jiahua Cui; Shaoshun Li
Journal:  RSC Adv       Date:  2018-04-20       Impact factor: 3.361

10.  Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism.

Authors:  Tareisha L Dunlap; Caitlin E Howell; Nita Mukand; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2017-10-19       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.